Abstract:Stroke is one of the most threatening diseases worldwide, particularly in countries with larger populations; it is associated with high morbidity, mortality and disability rates. As a result, extensive research efforts are being made to address these issues. Stroke can include either hemorrhagic stroke (blood vessel ruptures) or ischemic stroke (blockage of an artery). Whilst the incidence of stroke is higher in the elderly population (≥65), it is also increasing in the younger population. Ischemic stroke accounts for ~85% of all stroke cases. The pathogenesis of cerebral ischemic injury can include inflammation, excitotoxic injury, mitochondrial dysfunction, oxidative stress, ion imbalance and increased vascular permeability. All of the aforementioned processes have been extensively studied, providing insights into the disease. Other clinical consequences observed include brain edema, nerve injury, inflammation, motor deficits and cognitive impairment, which not only cause disabilities obstructing daily life but also increase the mortality rates. Ferroptosis is a type of cell death that is characterized by iron accumulation and increased lipid peroxidation in cells. In particular, ferroptosis has been previously implicated in ischemia-reperfusion injury in the central nervous system. It has also been identified as a mechanism involved in cerebral ischemic injury. The tumor suppressor p53 has been reported to modulate the ferroptotic signaling pathway, which both positively and negatively affects the prognosis of cerebral ischemia injury. The present review summarizes the recent findings on the molecular mechanisms of ferroptosis under the regulation of p53 underlying cerebral ischemia injury. Understanding of the p53/ferroptosis signaling pathway may provide insights into developing methods for improving the diagnosis, treatment and even prevention of stroke.

Molecular mechanisms and therapeutic strategies for ferroptosis and cuproptosis in ischemic stroke

Ferroptosis and Its Multifaceted Roles in Cerebral Stroke

Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

The role of ferroptosis and its mechanism in ischemic stroke

Progress of Ferroptosis in Ischemic Stroke and Therapeutic Targets

Elucidating the progress and impact of ferroptosis in hemorrhagic stroke

Inhibiting ferroptosis: A novel approach for stroke therapeutics

Cuproptosis in stroke: focusing on pathogenesis and treatment

Mechanism of ferroptosis regulating ischemic stroke and pharmacologically inhibiting ferroptosis in treatment of ischemic stroke

Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review)

Ferroptosis in Ischemic Stroke and Related Traditional Chinese Medicines

Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries

Progress of medicinal plants and their active metabolites in ischemia-reperfusion injury of stroke: a novel therapeutic strategy based on regulation of crosstalk between mitophagy and ferroptosis

Interactions Between Ferroptosis and Oxidative Stress in Ischemic Stroke

A New Perspective in the Treatment of Ischemic Stroke: Ferroptosis

Multifaceted Role of Ferroptosis in Cardiovascular Disease

Iron, Ferroptosis, and Ischemic Stroke

Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives

Traditional Chinese medicines derived natural inhibitors of ferroptosis on ischemic stroke

Crosstalk between Oxidative Stress and Ferroptosis/Oxytosis in Ischemic Stroke: Possible Targets and Molecular Mechanisms